/CON
CON Stock - Concentra Group Holdings Parent, Inc.
Healthcare|Medical - Equipment & ServicesNYSE
$19.43-0.97%
$0.19 (-0.97%) • Dec 19
72
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.36
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).100
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.92
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+167.6%upside
Target: $51.99
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for CON
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$19.24 – $19.62
TARGET (TP)$52.00
STOP LOSS$17.88
RISK/REWARD1:21.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.69
52W High$24.17
52W Low$18.55
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | $1.90B | $1.84B | $1.72B | $1.73B |
| Gross Profit | $527.98M | $512.43M | $408.19M | $427.98M |
| Gross Margin | 27.8% | 27.9% | 23.7% | 24.7% |
| Operating Income | $304.76M | $287.63M | $258.22M | $270.26M |
| Net Income | $166.54M | $179.95M | $166.73M | $208.88M |
| Net Margin | 8.8% | 9.8% | 9.7% | 12.1% |
| EPS | $1.30 | $1.42 | $1.32 | $1.65 |
Company Overview
Concentra Group Holdings Parent, Inc. provides occupational health services in the United States. The company offers occupational and consumer health services, including workers' compensation injury care, urgent care, clinical testing, preventative care, and employer services, as well as wellness programs through occupational health centers and onsite clinics. It also provides Concentra Telemed, a telemedicine solution for the treatment of work-related injuries and illnesses, and employer services; pharmacy solution under the Concentra Pharmacy name; and Concentra Medical Compliance Administration, a third-party administrator that helps to manage abuse testing programs for employers with regulated or non-regulated workforces. The company was founded in 1979 and is based in Mechanicsburg, Pennsylvania. Concentra Group Holdings Parent, Inc. operates as a subsidiary of Select Medical Corporation.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
7
88%
Hold / Neutral
1
13%
Sell / Underperform
0%
Analyst Consensus🟢 Bullish
7 Bullish1 Neutral/Bearish
Price Targets
$29
Average Target
↑ 47.2% Upside
Now
$24
Low
$29
Average
$33
High
Based on 10 analysts
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| September 18th 2025 | JP Morgan | Resumed | Overweight | $31 |
| December 16th 2024 | BofA Securities | Upgrade | Buy | $24 |
| October 7th 2024 | BofA Securities | Downgrade | Neutral | $24← $30.5 |
| August 20th 2024 | RBC Capital Mkts | Initiation | Outperform | $33 |
| August 19th 2024 | BofA Securities | Initiation | Buy | - |
| August 19th 2024 | Deutsche Bank | Initiation | Buy | $29 |
| August 19th 2024 | JP Morgan | Initiation | Overweight | $29 |
| August 19th 2024 | Goldman | Initiation | Buy | $32 |
| August 19th 2024 | Mizuho | Initiation | Outperform | $28 |
| August 19th 2024 | Wells Fargo | Initiation | Overweight | $27 |
| August 19th 2024 | Truist | Initiation | Buy | $29 |
Earnings History & Surprises
CONBeat Rate
67%
Last 6 quarters
Avg Surprise
+-0.0%
EPS vs Estimate
Beats / Misses
4/1
1 met exactly
Latest EPS
$0.39
Q4 2025
EPS Surprise History
Q4 23
No data
Q1 24
No data
Q3 24
-17.9%
$0.41vs$0.50
Q4 24
+2.8%
$0.37vs$0.36
Q1 25
+6.3%
$0.17vs$0.16
Q2 25
+3.2%
$0.32vs$0.31
Q3 25
0.0%
$0.37vs$0.37
Q4 25
+5.4%
$0.39vs$0.37
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 5, 2026 | — | — | — | — |
Q1 2026 | Mar 2, 2026 | $0.22 | — | — | — |
Q4 2025 | Nov 6, 2025 | $0.37 | $0.39 | +5.4% | ✓ BEAT |
Q3 2025 | Aug 7, 2025 | $0.37 | $0.37 | 0.0% | = MET |
Q2 2025 | May 7, 2025 | $0.31 | $0.32 | +3.2% | ✓ BEAT |
Q1 2025 | Mar 3, 2025 | $0.16 | $0.17 | +6.3% | ✓ BEAT |
Q4 2024 | Oct 31, 2024 | $0.36 | $0.37 | +2.8% | ✓ BEAT |
Q3 2024 | Jul 26, 2024 | $0.50 | $0.41 | -17.9% | ✗ MISS |
Q1 2024 | Mar 31, 2024 | — | $0.39 | — | — |
Q4 2023 | Dec 31, 2023 | — | $-0.19 | — | — |
Q3 2023 | Sep 30, 2023 | — | $0.42 | — | — |
Q2 2023 | Jun 30, 2023 | — | $0.42 | — | — |
Q1 2023 | Mar 31, 2023 | — | $0.37 | — | — |
Latest News
Concentra Group Holdings Raises FY2025 Sales Guidance from $2.130B-$2.160B to $2.145B-$2.160B vs $2.148B Est
➖ NeutralBenzinga•Nov 6, 2025, 09:32 PM
Concentra Group Holdings Q3 Adj. EPS $0.39 Beats $0.38 Estimate, Sales $572.800M Beat $562.757M Estimate
📈 PositiveBenzinga•Nov 6, 2025, 09:31 PM
JP Morgan Assumes Concentra Group Holdings at Overweight, Announces Price Target of $31
📈 PositiveBenzinga•Sep 18, 2025, 11:00 AM•Also:
CARGO Therapeutics to be acquired by Concentra Biosciences in $4.379/share cash deal plus CVR; stock rises 8%
📈 PositiveSeeking Alpha•Jul 8, 2025, 10:44 AM•Also:
IGM Biosciences climbs on merger deal with Concentra
📈 PositiveSeeking Alpha•Jul 1, 2025, 04:19 PM•Also:
Frequently Asked Questions about CON
What is CON's current stock price?
Concentra Group Holdings Parent, Inc. (CON) is currently trading at $19.43 per share. The stock has moved -0.97% today.
What is the analyst price target for CON?
The average analyst price target for CON is $52.00, based on 1 analyst.
What sector is Concentra Group Holdings Parent, Inc. in?
Concentra Group Holdings Parent, Inc. operates in the Healthcare sector, specifically within the Medical - Equipment & Services industry. The company is traded on the NYSE exchange.
What is CON's market cap?
Concentra Group Holdings Parent, Inc. has a market capitalization of $2.49 billion, making it a mid-cap company.
Does CON pay dividends?
No, Concentra Group Holdings Parent, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorADUS
Addus HomeCare Corporation
$112.82
Mkt Cap: $2.1B
BEAM
Beam Therapeutics Inc.
$26.57
Mkt Cap: $2.7B
BHC
Bausch Health Companies Inc.
$6.88
Mkt Cap: $2.5B
CPRX
Catalyst Pharmaceuticals, Inc.
$23.74
Mkt Cap: $2.9B
HAE
Haemonetics Corporation
$80.21
Mkt Cap: $3.9B
HCM
HUTCHMED (China) Limited
$13.55
Mkt Cap: $2.4B
ITGR
Integer Holdings Corporation
$78.58
Mkt Cap: $2.8B
PBH
Prestige Consumer Healthcare Inc.
$61.74
Mkt Cap: $3.1B
PINC
Premier, Inc.
$28.26
Mkt Cap: $2.3B
XRAY
DENTSPLY SIRONA Inc.
$11.21
Mkt Cap: $2.2B
Explore stocks similar to CON for comparison